Effects of ICD implantation on quality-adjusted life years in patients with congestive heart failure

被引:4
|
作者
Ozasa, Neiko [2 ]
Morimoto, Takeshi [1 ]
Furukawa, Yutaka [2 ]
Shizuta, Satoshi [2 ]
Nishiyama, Kei [2 ]
Kita, Toru [2 ]
Kimura, Takeshi [2 ]
机构
[1] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan
关键词
decision analysis; implantable cardioverter-defibrillator; primary prevention; quality-adjusted life years; reduced left ventricular ejection fraction;
D O I
10.1016/j.ijcard.2006.11.216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Effects of prophylactic implantable cardioverter-defibrillator (ICD) on quality-adjusted life years (QALYs) in patients with congestive heart failure are uncertain. Methods: We developed a decision model for patients at risk of sudden death due to reduced ejection fraction and who had no history of life-threatening ventricular arrhythmias. It estimated the QALYs for ICD strategy as a primary prevention for sudden cardiac death and conventional strategy without antiarrhythmic therapies. Results: In a 3-year time period, the QALYs for patients with conventional strategy were higher than that of ICD strategy (2.19 years vs. 2.14 years). When the mortality rate of conventional strategy exceeded 8.6%/year and the hazard ratio of death for the ICD strategy was lower than 0.70, the ICD strategy was the superior treatment option. Conclusions: The QALYs of patients with ICD could be lower than that of conventional strategy. Incorporating quality of life could affect decision making of ICD implantation. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:213 / 216
页数:4
相关论文
共 50 条
  • [31] Quality of life in older patients with congestive heart failure - Effects of ACE inhibitors
    Fergus, I
    Demopoulos, LA
    LeJemtel, TH
    DRUGS & AGING, 1996, 8 (01) : 23 - 28
  • [32] Composite measures for hospital quality using quality-adjusted life years
    Timbie, Justin W.
    Shahian, David M.
    Newhouse, Joseph P.
    Rosenthal, Meredith B.
    Normand, Sharon-Lise T.
    STATISTICS IN MEDICINE, 2009, 28 (08) : 1238 - 1254
  • [33] Optimizing sampling strategies for estimating quality-adjusted life years
    Ramsey, SD
    Etzioni, R
    Troxel, A
    Urban, N
    MEDICAL DECISION MAKING, 1997, 17 (04) : 431 - 438
  • [34] QUALITY-ADJUSTED LIFE YEARS - ORIGINS, MEASUREMENTS, APPLICATIONS, OBJECTIONS
    SCHWARTZ, S
    RICHARDSON, J
    GLASZIOU, PP
    AUSTRALIAN JOURNAL OF PUBLIC HEALTH, 1993, 17 (03): : 272 - 278
  • [35] Calibration of Quality-Adjusted Life Years for Oncology Clinical Trials
    Sloan, Jeff A.
    Sargent, Daniel J.
    Novotny, Paul J.
    Decker, Paul A.
    Marks, Randolph S.
    Nelson, Heidi
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 47 (06) : 1091 - +
  • [36] Quality-adjusted life years in cancer: pros, cons, and alternatives
    Woodward, R. M.
    Menzin, J.
    Neumann, P. J.
    EUROPEAN JOURNAL OF CANCER CARE, 2013, 22 (01) : 12 - 19
  • [37] Impact of Hip and Vertebral Fractures on Quality-Adjusted Life Years
    A. N. A. Tosteson
    S. E. Gabriel
    M. R. Grove
    M. M. Moncur
    T. S. Kneeland
    L. J. Melton III
    Osteoporosis International, 2001, 12 : 1042 - 1049
  • [38] Understanding quality-adjusted life years and their application to pharmacoeconomic research
    Raisch, DW
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (7-8) : 906 - 914
  • [39] Comparison of two methods of calculating quality-adjusted life years
    Ganiats, TG
    Browner, DK
    Kaplan, RM
    QUALITY OF LIFE RESEARCH, 1996, 5 (01) : 162 - 164
  • [40] Quality-adjusted life years (QALYs) and substance use disorders
    Pyne, Jeffrey M.
    French, Michael
    McCollister, Kathryn
    Tripathi, Shanti
    Rapp, Richard
    Booth, Brenda
    ADDICTION, 2008, 103 (08) : 1331 - 1332